Literature DB >> 26907217

Galectins and Immune Responses-Just How Do They Do Those Things They Do?

Sandra Thiemann1, Linda G Baum1.   

Abstract

Galectins are a family of mammalian carbohydrate-binding proteins expressed by many cell types. Galectins can function intracellularly and can also be secreted to bind to cell surface glycoconjugate counterreceptors. Some galectins are made by immune cells, whereas other galectins are secreted by different cell types, such as endothelial or epithelial cells, and bind to immune cells to regulate immune responses. Galectin binding to a single glycan ligand is a low-affinity interaction, but the multivalency of galectins and the glycan ligands presented on cell surface glycoproteins results in high-avidity binding that can reversibly scaffold or cluster these glycoproteins. Galectin binding to a specific glycoprotein counterreceptor is regulated in part by the repertoire of glycosyltransferase enzymes (which make the glycan ligands) expressed by that cell, and the effect of galectin binding results from clustering or retention of specific glycoprotein counterreceptors bearing these specific ligands.

Entities:  

Keywords:  CRD; carbohydrate recognition domain; glycan ligand; glycosyltransferase; lactosamine; lattice

Mesh:

Substances:

Year:  2016        PMID: 26907217     DOI: 10.1146/annurev-immunol-041015-055402

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  77 in total

1.  Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.

Authors:  Verónica C Martínez Allo; Vanesa Hauk; Nicolas Sarbia; Nicolás A Pinto; Diego O Croci; Tomás Dalotto-Moreno; Rosa M Morales; Sabrina G Gatto; Montana N Manselle Cocco; Juan C Stupirski; Ángel Deladoey; Esteban Maronna; Priscila Marcaida; Virginia Durigan; Anastasia Secco; Marta Mamani; Alicia Dos Santos; Antonio Catalán Pellet; Claudia Pérez Leiros; Gabriel A Rabinovich; Marta A Toscano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

Review 2.  Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.

Authors:  Donella M Beckwith; Maré Cudic
Journal:  Semin Immunol       Date:  2020-01-09       Impact factor: 11.130

Review 3.  Engineering galectin-glycan interactions for immunotherapy and immunomodulation.

Authors:  Shaheen A Farhadi; Gregory A Hudalla
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

Review 4.  Recognition of microbial glycans by soluble human lectins.

Authors:  Darryl A Wesener; Amanda Dugan; Laura L Kiessling
Journal:  Curr Opin Struct Biol       Date:  2017-05-05       Impact factor: 6.809

5.  Galectin-9 binds to O-glycans on protein disulfide isomerase.

Authors:  Katrin Schaefer; Nicholas E Webb; Mabel Pang; Jenny E Hernandez-Davies; Katharine P Lee; Pascual Gonzalez; Martin V Douglass; Benhur Lee; Linda G Baum
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

6.  Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.

Authors:  Mathias Ingemann Nielsen; John Stegmayr; Oliver C Grant; Zhang Yang; Ulf J Nilsson; Irene Boos; Michael C Carlsson; Robert J Woods; Carlo Unverzagt; Hakon Leffler; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

7.  Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation.

Authors:  Zihan Zhao; Xuejiao Xu; Hairong Cheng; Michelle C Miller; Zhen He; Hongming Gu; Zhongyu Zhang; Avraham Raz; Kevin H Mayo; Guihua Tai; Yifa Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

8.  Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways.

Authors:  Asmi Chakraborty; Caleb Staudinger; Sandra L King; Frances Clemente Erickson; Lee Seng Lau; Angela Bernasconi; Francis W Luscinskas; Chad Perlyn; Charles J Dimitroff
Journal:  J Autoimmun       Date:  2020-12-04       Impact factor: 7.094

9.  Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD).

Authors:  Haruki Matsumoto; Yuya Fujita; Naoki Matsuoka; Jumpei Temmoku; Makiko Yashiro-Furuya; Tomoyuki Asano; Shuzo Sato; Hiroshi Watanabe; Eiji Suzuki; Sosuke Tsuji; Shoichi Fukui; Masataka Umeda; Naoki Iwamoto; Atsushi Kawakami; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2021-05-24       Impact factor: 5.156

10.  Galectin-3 promotes noncanonical inflammasome activation through intracellular binding to lipopolysaccharide glycans.

Authors:  Tzu-Han Lo; Hung-Lin Chen; Cheng-I Yao; I-Chun Weng; Chi-Shan Li; Chi-Chun Huang; Nien-Jung Chen; Chun-Hung Lin; Fu-Tong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.